10X Fund, L.P. - Feb 2, 2022 Form 4 Insider Report for GALECTIN THERAPEUTICS INC (GALT)

Role
10%+ Owner
Signature
/s/ James C. Czirr, as Managing Member of the General Partner for 10X Fund, LP
Stock symbol
GALT
Transactions as of
Feb 2, 2022
Transactions value $
-$21,000
Form type
4
Date filed
2/4/2022, 05:23 PM
Previous filing
Jan 13, 2022
Next filing
Aug 9, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GALT Common Stock Sale -$21K -10K -0.16% $2.10 6.18M Feb 2, 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares sold pursuant to 10X Fund, LP's Rule 10b5-1 trading plan.
F2 10X Fund, L.P. has direct beneficial ownership of all the securities owned by 10X Fund, L.P. 10X Capital Management, LLC, a Florida limited liability company, is the general partner of 10X Fund, L.P., a Delaware limited partnership, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P., but disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein. James C. Czirr is the manager of 10X Capital Management, LLC, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P. and 10X Capital Management, LLC., but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.